Figure 4From: Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinomaKaplan-Meier disease specific (left) and overall (right) survival curves for GPR54 positivity within the clear cell subtype.Back to article page